Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2001

01-03-2001 | Revisiones

Pharmacogenomic research and serum DNA analysis in the treatment of non-small cell lung cancer

Authors: Rafael Rosell, MD, Aurora O'Brate, Mariano Monzó, José Miguel Sánchez, Mónica Guillot, Jacek Jassem, José Javier Sánchez, Albert Abad, Daniel Escuin, Miquel Tarón, Ewa Jassem

Published in: Clinical and Translational Oncology | Issue 2/2001

Login to get access
Metadata
Title
Pharmacogenomic research and serum DNA analysis in the treatment of non-small cell lung cancer
Authors
Rafael Rosell, MD
Aurora O'Brate
Mariano Monzó
José Miguel Sánchez
Mónica Guillot
Jacek Jassem
José Javier Sánchez
Albert Abad
Daniel Escuin
Miquel Tarón
Ewa Jassem
Publication date
01-03-2001
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2001
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02711456

Other articles of this Issue 2/2001

Clinical and Translational Oncology 2/2001 Go to the issue

Originales

Situación de la braquiterapia en España. Análisis de complejidad y tiempos de preparación y tratamiento

Notas Clínicas

Primary lung choriocarcinoma

Revisiones

Optimal treatment for poor prognosis isolated colorectal carcinoma liver metastases. Rationality for prospective neoadjuvant clinical trials

Originales

Increase in the incidence of non-Hodgkin’s lymphoma, clinical features and long-term follow-up

Notas Clínicas

Anemia hemolítica microangiopática y metástasis cardíaca por carcinoma de cabeza y cuello

Editorial

Fraud in clinical research
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits